Literature DB >> 2358670

IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

J A Elias1, V Lentz.   

Abstract

We characterized the effects of rIL-1 and rTNF on human lung fibroblast IL-6 production. rIL-1 was a potent stimulator, rTNF only marginally stimulated, and rIL-1 and rTNF in combination synergistically stimulated IL-6 protein production. These changes were associated with proportionate alterations in IL-6 mRNA accumulation. Nuclear run-on analysis demonstrated that the effects of rIL-1 and rTNF individually were associated with increased IL-6 gene transcription. In contrast, alterations in gene transcription could not fully explain the synergistic effects of rIL-1 and rTNF in combination. However, IL-6 mRNA was significantly more stable in cells stimulated with rIL-1 plus rTNF than in cells stimulated with rIL-1 alone. Thus the synergistic effects of rIL-1 and rTNF in combination were mediated, at least partially, by an alteration in the stability of IL-6 mRNA. Alterations in mRNA stability may be an important mechanism of cytokine-cytokine synergy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358670

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Increase in portal blood interleukin-6 soon after the commencement of digestive surgery.

Authors:  T Maeba; H Maeta; H Usuki; H Wakabayashi; T Tsubouchi; S Okada; T Takeda; I Hamamoto; K Okano; K Ishimura
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.

Authors:  S M Hsu; S S Xie; P L Hsu; J A Waldron
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

4.  Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1.

Authors:  C Southern; D Schulster; I C Green
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

5.  Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases.

Authors:  Ferit Avcu; A Ugur Ural; M Ilker Yilmaz; Necati Bingol; Oral Nevruz; Kayser Caglar
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

6.  The mRNA-binding protein Zfp36 is upregulated by β-adrenergic stimulation and represses IL-6 production in 3T3-L1 adipocytes.

Authors:  Pavna K Brahma; Huanchun Zhang; Betsy S Murray; Feng-jue Shu; Neil Sidell; Emre Seli; Caleb B Kallen
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

Review 7.  Cytokines in the pathogenesis of osteoporosis.

Authors:  E Romas; T J Martin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

8.  A synergistic relationship between TNF-alpha, IL-1 beta, and TGF-beta 1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line.

Authors:  D W McGee; T Bamberg; S J Vitkus; J R McGhee
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Removal of a 3' non-coding sequence is an initial step in degradation of gro alpha mRNA and is regulated by interleukin-1.

Authors:  M Y Stoeckle
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

10.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.